BSE: 526955 | NSE: | Pharmaceuticals & Drugs | Small Cap
1. Is ABL Biotechnologies Ltd. a good quality company?
Data is not available for this company.
2. Is ABL Biotechnologies Ltd. undervalued or overvalued?
No data found
3. Is ABL Biotechnologies Ltd. a good buy now?
No data found
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
Value Creation ⓘ
Value Creation Index Colour Code Guide ⓘ
|ROCE % ⓘ||-3.5%||2.8%||12.1%||24.9%||15.8%||10.5%||-0.4%||-43.7%||-1.7%||-0.5%||-|
Growth Parameters ⓘ
Growth Parameters Colour Code Guide ⓘ
|YoY Gr. Rt. %||-||1,400%||127.5%||20.9%||32.2%||81.9%||-51.7%||-72.8%||-98.2%||-100%||-|
|Adj EPS ⓘ||-0.4||0.2||1||4.1||5.3||4.4||-1.2||-25.2||-0.7||-0.2||-0.2|
|YoY Gr. Rt. %||-||NA||325%||302%||28.3%||-16.9%||-126.8%||NA||NA||NA||-|
|BVPS (₹) ⓘ||5.6||5.5||6.2||9||16.6||20.4||43.3||18.4||17.8||17.6||16.9|
|Adj Net Profit ⓘ||-0.1||0.1||0.4||1.7||2.2||1.8||-1||-20.6||-0.6||-0.2||0|
|Cash Flow from Ops. ⓘ||0||0.6||0.6||-3.6||1.8||-1.7||0.8||-9.6||-0.5||-0.1||-|
|Debt/CF from Ops. ⓘ||78.5||1.8||2.8||-1.4||5.7||-8.6||21.3||-1.7||-36.2||-148.9||-|
CAGR Colour Code Guide ⓘ
|9 Years||5 Years||3 Years||1 Years|
|Adj EPS ⓘ||NA||-153%||NA||NA|
Key Financial Parameters ⓘ
Performance Ratio Colour Code Guide ⓘ
|Return on Equity % ⓘ||-5.2||3.7||13.7||40||24.6||14.3||-3.6||-69.3||-3.2||-1||-0.9|
|Op. Profit Mgn % ⓘ||-114||7.7||11.4||17.7||18.6||19.2||4.9||-899.2||-1266||0||0|
|Net Profit Mgn % ⓘ||-83.6||3.9||7.2||24||23.3||10.6||-11.7||-927.8||-1425||0||0|
|Debt to Equity ⓘ||0.6||0.5||0.6||1.4||1.5||1.7||0.5||1.1||1.2||1.2||0.7|
|Working Cap Days ⓘ||310||68||69||182||264||253||646||1,613||74,662||0||0|
|Cash Conv. Cycle ⓘ||-179||-79||-71||-51||-39||-19||-34||-21||-9,356||0||0|
No data to display
Return on Equity has declined versus last 3 years average to %
Sales growth has been subdued in last 3 years %
Sales growth is not so good in last 4 quarters at %
|TTM EPS (₹)||-0.2||-0.2|
|TTM Sales (₹ Cr.)||0||0|
|BVPS (₹.) ⓘ||16.9||16.9|
|Reserves (₹ Cr.) ⓘ||6||6|
|From the Market|
|52 Week Low / High (₹)||0.75 / 0.81|
|All Time Low / High (₹)||0.73 / 222.00|
|Market Cap (₹ Cr.)||0.7|
|Equity (₹ Cr.)||8.2|
|Face Value (₹)||10|
|Industry PE ⓘ||38|
ABL Biotechnologies incorporated in 1992, is a pioneer in harnessing the biodiversity of the Indian marine environment. ABL is engagaed in identification and commercial extraction of bio-chemicals, predominantly from microbes, that are used as nutritional, cosmetic, pharmaceutical, and industrial intermediates.
Companyâ€™s R&D unit is located at Vishakapatnam that has been recognised by the Department of Scientific and Industrial Research, Ministry of Science and Technology, Government of India.
Companyâ€™s microbial metabolites laboratory located at Chennai is focused on evaluating new sources of biochemicals from marine organisms.
Company has collaborated with institutions such as the National Facility for Marine Cyanobacteria, Bharathidasan University, Trichy, the National Institute of Oceanography, The Madras University and the Dr.A.L.M Post Graduate Institute of Medical Sciences, Madras to introduce joint development programmes of advanced research in India.
Company has taken various initiatives such as sale or licensing of technologies, development of biochemical intermediates, conducting research on aquatic biotechnology, product development for therapeutics industry and undertaking contract research. Under contract research company manufactures finished formulations in various formats including soft and hard gelatine capsules, tablets, liquid orals and topical ointments, for various disease states.
ABL has been conducting research on polysaccharides, essential fatty acids, natural pigments, tracers and tags with considerable success. Presently company is focus on developing pharmaceuticals products catering various areas like anti-bacterials and anti-virals, enzymes, bio-molecular materials, bio-monitors and diagnostics, bio-pesticides, bioremediation and aquaculture.
Company manufactures Beta carotene, which is used as a source of Vitamin A for protection against strokes and cataracts, enhancing the immune system, and preventing photo sensitivity disorders.ABL manufactures Lycopene, an antioxidant carotenoid and pigment that gives characteristic red colour to tomatoes, watermelon, and pink grapefruit.Company developed Lutein, a carotenoid found in fruits and vegetables, including dark green and leafy vegetables, such as spinach and kale, as well as in foods comprising corn and egg yolks.ABL Biotechnologies involves in the production of carotenoid fortified products, including jams, squashes, ketchups and sauces, cooking oils, and chocolates.
ABL Biotechnologies R&D unit plans to strengthen its product portfolio by developing new molecules.